Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Al-Adwani, A.
1995.
Brain damage and tardive dyskinesia.
British Journal of Psychiatry,
Vol. 167,
Issue. 3,
p.
410.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 4,
p.
690.
McGrath, Patrick J.
Quitkin, Frederic M.
and
Klein, Donald F.
1995.
Bromocriptine Treatment of Relapses Seen During Selective Serotonin Re-uptake Inhibitor Treatment of Depression.
Journal of Clinical Psychopharmacology,
Vol. 15,
Issue. 4,
p.
289.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 3,
p.
516.
Fitzgerald, K.
and
Healy, D.
1995.
Dystonias and dyskinesias of the jaw associated with the use of SSRIs.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. 3,
p.
215.
Devane, C. Lindsay
1995.
Comparative safety and tolerability of selective serotonin reuptake inhibitors.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. S3,
p.
S185.
Tiihonen, J.
Kuoppamäki, M.
Syvälahti, E.
Någren, K.
Eronen, E.
Hietala, J.
and
Bergman, J.
1996.
Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.
Psychopharmacology,
Vol. 126,
Issue. 4,
p.
277.
Basson, Rosemary
1996.
Sexuality and parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 2,
Issue. 4,
p.
177.
Vandel, P.
Bonin, B.
Vandel, S.
Sechter, D.
and
Bizouard, P.
1996.
CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects.
Medical Hypotheses,
Vol. 47,
Issue. 6,
p.
439.
Thomas, P
Roche, J
Maron, M
Cotencin, O
Vaiva, G
and
Goudemand, M
1996.
Severe extrapyramidal symptoms with fluvoxamine despite neuroleptics withdrawal.
European Psychiatry,
Vol. 11,
Issue. 5,
p.
273.
Salokangas, R. K. R.
Saarijärvi, S.
Taiminen, T.
Kallioniemi, H.
Lehto, H.
Niemi, H.
Tuominen, J.
Ahola, V.
and
Syvälahti, E.
1996.
Citalopram as an adjuvant in chronic schizophrenia: a double‐blind placebo‐controlled study.
Acta Psychiatrica Scandinavica,
Vol. 94,
Issue. 3,
p.
175.
Jellinger, Kurt A.
1996.
Handbuch der Gerontopsychiatrie.
p.
202.
Armitage, Roseanne
1996.
Effects of Antidepressant Treatment on Sleep EEG in Depression.
Journal of Psychopharmacology,
Vol. 10,
Issue. 1_suppl,
p.
22.
Suzuki, Toshihito
Kurita, Hirofumi
Hori, Takafumi
Sasaki, Megumi
Baba, Atsuomi
Shiraishi, Hiroyasu
and
Piletz, John E.
1997.
The pisa syndrome (pleurothotonus) during antidepressant therapy.
Biological Psychiatry,
Vol. 41,
Issue. 2,
p.
234.
Fox, G. C.
Ebeld, S.
and
Vincenti, G.
1997.
Paroxetine-induced chorea.
British Journal of Psychiatry,
Vol. 170,
Issue. 2,
p.
193.
GORMLEY, NIALL
WATTERS, LIAM
and
LAWLOR, BRIAN A.
1997.
Extrapyramidal Side-Effects in Elderly Patients Exposed to Selective Serotonin Reuptake Inhibitors.
Human Psychopharmacology: Clinical and Experimental,
Vol. 12,
Issue. 2,
p.
139.
Schreiber, Shaul
and
Pick, Chaim G.
1997.
Paroxetine for Secondary Stuttering: Further Interaction of Serotonin and Dopamine.
The Journal of Nervous & Mental Disease,
Vol. 185,
Issue. 7,
p.
465.
Poyurovsky, Michael
Schneidman, Michael
and
Weizman, Abraham
1997.
Successful treatment of fluoxetine‐indueed dystonia with low‐dose mianserin.
Movement Disorders,
Vol. 12,
Issue. 6,
p.
1102.
Fujita, Masahiro
Takatoku, Keizo
Matoba, Yoshinori
Nishiura, Masaru
Kobayashi, Kaoru
Nishimura, Tsunehiko
and
Inoue, Osamu
1997.
Enhancement of [123I]?-CIT binding in the striatum with clomipramine: Is there a serotonin-dopamine interaction?.
European Journal of Nuclear Medicine,
Vol. 24,
Issue. 4,
p.
403.
1997.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 31,
Issue. 5,
p.
772.
eLetters
No eLetters have been published for this article.